THNR

Amplify Weight Loss Drug & Treatment ETF · PSE

Category Equity
Expense Ratio 0.59%
Listing Date May 21, 2024
Volume 2,369.0
Market Cap (AUM) $4.31M

Performance

-3.71%

+5.96%

+4.88%

+6.47%

YTD

+6.47%

Top Holdings

Name
Symbol
%Assets
Eli Lilly and CompanyLLY16.69%
Novo Nordisk A/S Class BNOVO.B15.37%
AstraZeneca PLCAZN5.90%
Amgen Inc.AMGN5.49%
FUJIFILM Holdings Corp49015.49%
Merck KGaAMRK5.17%
Merck & Co., Inc.MRK5.04%
Roche Holding Ltd Dividend Right Cert.ROG5.03%
Pfizer Inc.PFE5.01%
Catalent IncCTLT4.79%

Advanced Technical Analysis

Recent News & Updates

2024-09-04 00:26
3 ETFs to stabilize a portfolio amid volatility: Amplify CEO(Yahoo Finance)
2024-06-04 19:00
Amplify ETFs Earns Four Nominations for With Intelligence Mutual Fund and ETF Awards(Yahoo Finance)
2024-05-20 19:00
Amplify ETFs Launches The Amplify Weight Loss Drug & Treatment ETF (THNR)(Yahoo Finance)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.